Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06016920
Title Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nykode Therapeutics ASA
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | NOR | HUN | GBR | FRA | ESP | DEU | CZE


No variant requirements are available.